NCT01270971 - Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail | Biotech Hunter

Enrollment

594

Participants

Timeline

Start Date

December 1, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

January 8, 2013

Conditions

Onychomycosis of Toenails

Interventions

DRUG

AN2690 Topical Solution, 5%

AN2690 Topical Solution, 5%, applied once daily for 48 weeks

DRUG

Solution Vehicle

AN2690 Topical Solution, Vehicle, applied once daily for 48 weeks

Trial Locations (27)

10011

Investigational Site, New York

10155

Investigational Site, New York

14623

Investigational Site, Rochester

21214

Investigational Site, Baltimore

24501

Investigational Site, Lynchburg

27157

Investigational Site, Winston-Salem

32073

Investigational Site, Orange Park

38138

Investigational Site, Germantown

44118

Investigational Site, South Euclid

45249

Investigational Site, Cincinnati

47713

Investigational Site, Evansville

55432

Investigational Site, Fridley

66202

Investigational Site, Overland Park

68144

Investigational Site, Omaha

71913

Investigational Site, Hot Springs

77845

Investigational Site, College Station

78229

Investigational Site, San Antonio

78759

Investigational Site, Austin

80210

Investigational Site, Denver

83686

Investigational Site, Boise

85741

Investigational Site, Tucson

90045

Investigational Site, Los Angeles

91505

Investigational Site, Burbank

94115

Investigational Site, San Francisco

97210

Investigational Site, Portland

99204

Investigational Site, Spokane

02920

Investigational Site, Providence